中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

79 records (took 0.042 seconds)

    Quantification of Gene Expression
    31.
    发明申请
    Quantification of Gene Expression 有权
    基因表达的定量

    公开(公告)号：US20120028838A1

    公开(公告)日：2012-02-02

    申请号：US13223923

    申请日：2011-09-01

    Applicant: Charles R. Cantor ,  Chunming Din

    Inventor： Charles R. Cantor ,  Chunming Din

    IPC: C12Q1/68 ,  C40B30/10

    CPC classification number: C12Q1/6851 ,  C12Q2545/107 ,  C12Q2535/125 ,  C12Q2525/186

    Abstract: The present invention relates to a method for measuring the amount of a target nucleic acid in a sample using a standard which is designed to have one base difference compared with the gene of interest or a “target nucleic acid sequence.” Use of such standard in combination with a method of “enhancing” the difference in the standard and the test nucleic acid sample using, for example, a base extension reaction carried right at the mutation site allowing amplification of the standard and target nucleic acids with the same efficiency and facilitating quantification of the target nucleic acid. Thereafter a means of quantifying the “enhanced” standard and target nucleic acid samples is used to determine the amount of the target nucleic acid. In the preferred embodiment, the quantification means is Mass Spectrometry.

    Abstract translation: 本发明涉及使用与目的基因相比具有一个碱基差异的标准或“靶核酸序列”来测量样品中靶核酸量的方法。使用这种标准物 结合使用例如在突变位点上携带的碱基延伸反应来“提高”标准差和测试核酸样品的方法，允许以相同的效率扩增标准品和靶核酸并促进定量 的靶核酸。 此后，使用定量“增强”标准和靶核酸样品的手段来确定靶核酸的量。 在优选实施方案中，定量方法是质谱法。

    SUPRAMOLECULAR BIOCONJUGATES
    32.
    发明申请
    SUPRAMOLECULAR BIOCONJUGATES 审中-公开

    公开(公告)号：US20100255558A1

    公开(公告)日：2010-10-07

    申请号：US12435665

    申请日：2009-05-05

    Applicant: Christof M. Niemeyer ,  Charles R. Cantor ,  Takeshi Sano ,  Cassandra L. Smith

    Inventor： Christof M. Niemeyer ,  Charles R. Cantor ,  Takeshi Sano ,  Cassandra L. Smith

    IPC: C07K17/00 ,  C07K1/00 ,  C12N9/96

    CPC classification number: B82Y5/00 ,  A61K47/54 ,  A61K47/55 ,  A61K47/557 ,  A61K47/6949 ,  A61K51/1268 ,  C03C17/30 ,  C03C17/3405 ,  C12Q1/6804 ,  C12Q1/682

    Abstract: The invention relates to supramolecular bioconjugates and to methods for assembling and utilizing supramolecular bioconjugates. Supramolecular bioconjugates comprise a plurality of first nucleic acids and a plurality of mediators wherein each mediator comprises a second nucleic acid complementary to a sequence within said plurality of first nucleic acids. To assemble a supramolecular bioconjugate, one or more sets of bioreactive agents are coupled to the plurality of mediators, forming a plurality of bioreactive complexes. The plurality of bioreactive complexes are hybridized to the plurality of first nucleic acids to form the supramolecular bioconjugate. Bioconjugates can be used to detect and isolate targets, to screen samples for targets such as antigens, to treat patients with multiple agents or to diagnose disorders in the form of a kit.

    Abstract translation: 本发明涉及超分子生物缀合物和组分和利用超分子生物缀合物的方法。 超分子生物缀合物包含多个第一核酸和多个介体，其中每个介体包含与所述多个第一核酸内的序列互补的第二核酸。 为了组装超分子生物缀合物，将一组或多组生物反应剂偶联至多个介体，形成多个生物反应性复合物。 多个生物反应性复合物与多个第一核酸杂交以形成超分子生物缀合物。 生物共轭物可用于检测和分离靶标，筛选靶标如抗原的样品，以治疗患有多种药物的患者或以试剂盒的形式诊断疾病。

    Methods for prenatal diagnosis of chromosomal abnormalities
    33.
    发明申请
    Methods for prenatal diagnosis of chromosomal abnormalities 有权
    产前诊断染色体异常的方法

    公开(公告)号：US20090325232A1

    公开(公告)日：2009-12-31

    申请号：US12553225

    申请日：2009-09-03

    Applicant: Charles R. Cantor ,  Chunming Ding

    Inventor： Charles R. Cantor ,  Chunming Ding

    IPC: C12P19/30

    CPC classification number: C12Q1/6883 ,  C12Q1/6806 ,  C12Q1/6827 ,  C12Q1/6876 ,  C12Q2600/154 ,  C12Q2600/156 ,  C12Q2600/166 ,  C12Q2521/331

    Abstract: Chromosomal abnormalities are responsible for a significant number of birth defects, including mental retardation. The present invention is related to methods for non-invasive and rapid, prenatal diagnosis of chromosomal abnormalities based on analysis of a maternal blood sample. The invention exploits the differences in DNA between the mother and fetus, for instance differences in their methylation states, as a means to enrich for fetal DNA in maternal plasma sample. The methods described herein can be used to detect chromosomal DNA deletions and duplications. In a preferred embodiment, the methods are used to diagnose chromosomal aneuploidy and related disorders, such as Down's and Turner's Syndrome.

    Abstract translation: 染色体异常负责大量的出生缺陷，包括精神发育迟滞。 本发明涉及基于母体血液样品分析的非侵入性和快速，产前诊断染色体异常的方法。 本发明利用母体和胎儿之间的DNA差异，例如甲基化状态的差异，作为富集母体血浆样品中胎儿DNA的手段。 本文描述的方法可用于检测染色体DNA缺失和重复。 在优选的实施方案中，所述方法用于诊断染色体非整倍体和相关疾病，例如唐氏和特纳综合征。

    Recombinant streptavidin-metallothionein chimeric protein having biological recognition specificity
    37.
    发明授权
    Recombinant streptavidin-metallothionein chimeric protein having biological recognition specificity 失效
    具有生物识别特异性的重组链霉抗生物素蛋白 - 金属硫蛋白嵌合蛋白

    公开(公告)号：US06391590B1

    公开(公告)日：2002-05-21

    申请号：US07780717

    申请日：1991-10-21

    Applicant: Takeshi Sano ,  Alexander N. Glazer ,  Charles R. Cantor

    Inventor： Takeshi Sano ,  Alexander N. Glazer ,  Charles R. Cantor

    IPC: C12N1562

    CPC classification number: C07H21/04 ,  C07K14/36 ,  C07K14/825 ,  C07K2319/00 ,  C07K2319/22

    Abstract: Streptavidin-metallothionein chimeric proteins with biological recognition specificity in which the streptavidin moiety provides high affinity biotin binding and the metallothionein moiety provides a high affinity metal binding. The binding affinity of the streptavidin-metallothionein chimeric protein both for biotin and heavy metal ions allows specific incorporation into, conjugation with, or labelling of any biological material containing biotin with various heavy metal ions.

    Abstract translation: 具有生物识别特异性的链霉亲和素 - 金属硫蛋白嵌合蛋白，其中链霉亲和素部分提供高亲和力生物素结合和金属硫蛋白部分提供高亲和力的金属结合。 链霉抗生物素蛋白 - 金属硫蛋白嵌合蛋白对生物素和重金属离子的结合亲和力允许特异性掺入，缀合或标记含有生物素与各种重金属离子的任何生物材料。

    Sequence directed DNA binding molecules compositions and methods
    38.
    发明授权
    Sequence directed DNA binding molecules compositions and methods 失效
    序列定向DNA结合分子的组成和方法

    公开(公告)号：US06384208B1

    公开(公告)日：2002-05-07

    申请号：US09354947

    申请日：1999-07-15

    Applicant: Cynthia A. Edwards ,  Charles R. Cantor ,  Beth M. Andrews ,  Lisa M. Turin ,  Kirk E. Fry

    Inventor： Cynthia A. Edwards ,  Charles R. Cantor ,  Beth M. Andrews ,  Lisa M. Turin ,  Kirk E. Fry

    IPC: C07H2104

    CPC classification number: C12Q1/701 ,  C07K14/47 ,  C12N15/1048 ,  C12N15/67 ,  C12Q1/6811 ,  C12Q1/6813 ,  C12Q1/6876 ,  C12Q1/6883 ,  C12Q1/705 ,  H01L2924/14 ,  C12Q2525/161 ,  C12Q2525/131 ,  C12Q2537/161 ,  C12Q2522/101 ,  C12Q2521/301

    Abstract: The present invention defines a DNA: protein-binding assay useful for screening libraries of synthetic or biological compounds for their ability to bind DNA test sequences. The assay is versatile in that any number of test sequences can be tested by placing the test sequence adjacent to a defined protein binding screening sequence. Binding of molecules to these test sequence changes the binding characteristics of the protein molecule to its cognate binding sequence. When such a molecule binds the test sequence the equilibrium of the DNA:protein complexes is disturbed, generating changes in the concentration of free DNA probe. Numerous exemplary target test sequences (SEQ ID NO:1 to SEQ ID NO:600) are set forth. The assay of the present invention is also useful to characterize the preferred binding sequences of any selected DNA-binding molecule.

    Abstract translation: 本发明定义了一种DNA：蛋白结合测定法，用于筛选合成或生物化合物文库结合DNA测试序列的能力。 该测定法是通用的，因为可以通过将测试序列置于与定义的蛋白质结合筛选序列相邻的位置来测试任何数量的测试序列。 分子与这些测试序列的结合改变了蛋白质分子与其同源结合序列的结合特征。 当这样的分子结合测试序列时，DNA：蛋白复合物的平衡受到干扰，产生游离DNA探针浓度的变化。 阐述了许多示例性目标测试序列（SEQ ID NO：1至SEQ ID NO：600）。 本发明的测定也可用于表征任何所选DNA结合分子的优选结合序列。

    Sequence-directed DNA-binding molecules compositions and methods
    39.
    发明授权
    Sequence-directed DNA-binding molecules compositions and methods 失效
    序列指导的DNA结合分子的组成和方法

    公开(公告)号：US5738990A

    公开(公告)日：1998-04-14

    申请号：US475221

    申请日：1995-06-07

    Applicant: Cynthia A. Edwards ,  Kirk E. Fry ,  Charles R. Cantor ,  Beth M. Andrews

    Inventor： Cynthia A. Edwards ,  Kirk E. Fry ,  Charles R. Cantor ,  Beth M. Andrews

    IPC: C07K14/47 ,  C12N15/09 ,  C12N15/10 ,  C12N15/67 ,  C12Q1/68 ,  C12Q1/70 ,  C12P21/02 ,  C07H21/04

    CPC classification number: C12N15/67 ,  C07K14/47 ,  C12N15/1048 ,  C12Q1/6811 ,  C12Q1/6883 ,  C12Q1/705

    Abstract: The present invention defines an assay useful for screening libraries of synthetic or biological compounds for their ability to bind specific DNA test sequences. The assay is also useful for determining the sequence specificity and relative DNA-binding affinity of DNA-binding molecules for any particular DNA sequence. Also described herein are potential applications of the assay, including: 1) the detection of lead compounds or new drugs via the mass screening of libraries of synthetic or biological compounds (i.e., fermentation broths); 2) the design of sequence-specific DNA-binding drugs comprised of homo- or hetero-meric subunits of molecules for which the sequence specificity was determined using the assay; and 3) the use of molecules for which sequence specificity was determined using the assay as covalently attached moieties to aid in the binding of nucleic acid or other macromolecular polymers to nucleic acid sequences.

    Abstract translation: 本发明定义了一种用于筛选合成或生物化合物文库以测定其结合特异性DNA测试序列的能力的测定法。 该测定还可用于确定DNA结合分子对于任何特定DNA序列的序列特异性和相对DNA结合亲和力。 本文还描述了测定的潜在应用，包括：1）通过大量筛选合成或生物化合物（即发酵液）文库来检测铅化合物或新药物; 2）由使用该测定法确定序列特异性的分子的同源或异源亚基组成的序列特异性DNA结合药物的设计; 和3）使用通过测定作为共价连接的部分确定序列特异性的分子，以有助于核酸或其它大分子聚合物与核酸序列的结合。

    Method of ordering sequence binding preferences of a DNA-binding molecule
    40.
    发明授权
    Method of ordering sequence binding preferences of a DNA-binding molecule 失效
    排序DNA结合分子的序列结合偏好的方法

    公开(公告)号：US5693463A

    公开(公告)日：1997-12-02

    申请号：US996783

    申请日：1992-12-23

    Applicant: Cynthia A. Edwards ,  Kirk E. Fry ,  Charles R. Cantor ,  Beth M. Andrews

    Inventor： Cynthia A. Edwards ,  Kirk E. Fry ,  Charles R. Cantor ,  Beth M. Andrews

    IPC: C07K14/47 ,  C12N15/09 ,  C12N15/10 ,  C12N15/67 ,  C12Q1/68 ,  C12Q1/70 ,  C07H21/02 ,  C12N15/00 ,  G01N33/574

    CPC classification number: C12N15/67 ,  C07K14/47 ,  C12N15/1048 ,  C12Q1/6811 ,  C12Q1/6883 ,  C12Q1/705

    Abstract: The present invention defines an assay useful for screening libraries of synthetic or biological compounds for their ability to bind specific DNA test sequences. The assay is also useful for determining the sequence specificity and relative DNA-binding affinity of DNA-binding molecules for any particular DNA sequence. Also described herein are potential applications of the assay, including: 1) the detection of lead compounds or new drugs via the mass screening of libraries of synthetic or biological compounds (i.e., fermentation broths); 2) the design of sequence-specific DNA-binding drugs comprised of homo- or hetero-meric subunits of molecules for which the sequence specificity was determined using the assay; and 3) the use of molecules for which sequence specificity was determined using the assay as covalently attached moieties to aid in the binding of nucleic acid or other macromolecular polymers to nucleic acid sequences.

    Abstract translation: 本发明定义了一种用于筛选合成或生物化合物文库以测定其结合特异性DNA测试序列的能力的测定法。 该测定还可用于确定DNA结合分子对于任何特定DNA序列的序列特异性和相对DNA结合亲和力。 本文还描述了测定的潜在应用，包括：1）通过大量筛选合成或生物化合物（即发酵液）文库来检测铅化合物或新药物; 2）由使用该测定法确定序列特异性的分子的同源或异源亚基组成的序列特异性DNA结合药物的设计; 和3）使用通过测定作为共价连接的部分确定序列特异性的分子，以有助于核酸或其它大分子聚合物与核酸序列的结合。

Patent Agency Ranking